Jun 24 |
Biofrontera Announces the Launch of a New, FDA-Approved Red Light Source, the RhodoLEDĀ® XL Lamp
|
May 16 |
Biofrontera Inc. (BFRI) Q1 2024 Earnings Call Transcript
|
May 15 |
Biofrontera GAAP EPS of -$2.88, revenue of $7.9M
|
May 15 |
Biofrontera Inc. Reports First Quarter 2024 Financial Results and Provides a Business Update
|
May 6 |
Biofrontera Inc. to Report First Quarter 2024 Financial Results on May 15, 2024
|
May 3 |
Biofrontera files to sell 11.31M shares for holders
|
May 3 |
Biofrontera Announces Achievement of Two Milestones Associated with Series B-3 Convertible Preferred Stock Warrants
|
Mar 26 |
Biofrontera Inc. Announces 2024 Annual Meeting of Stockholders and Deadlines for Submission of Stockholder Proposals
|
Mar 19 |
Biofrontera Inc. (NASDAQ:BFRI) Q4 2023 Earnings Call Transcript
|
Mar 19 |
Q4 2023 Biofrontera Inc Earnings Call
|